Related Experiment Video
Updated: Apr 21, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
A disease potential-driven graph attention model for comorbidity risk prediction of hypertension
Leming Zhou1, Hanshu Qin2, Yanmei Yang3
1School of Computer Science and Technology, Chongqing University of Posts and Telecommunications, Chongqing, China.
Insights
Hypertension patients face serious risks from comorbidities. A new Disease Potential-Driven Graph Attention (DP-GA) model improves comorbidity risk prediction, enhancing clinical interpretability and early detection.
Area of Science:
- Medical Informatics
- Computational Biology
- Cardiovascular Disease Research
Background:
- Hypertension significantly increases the risk of severe complications and comorbidities.
- Current data-driven comorbidity prediction models lack clinical plausibility and interpretability.
- Effective methods are needed to integrate patient features and identify individual differences for accurate risk prediction.
Purpose of the Study:
- To develop an advanced model for predicting hypertension comorbidities.
- To address limitations of existing data-driven prediction methods.
- To enhance the interpretability and early detection of hypertension-related comorbidities.
Main Methods:
- Proposed a novel Disease Potential-Driven Graph Attention (DP-GA) model.
- Integrated patient disease features and structural information using a fusion mechanism.
- Implemented a similarity-difference balance mechanism to differentiate patient relationships.
- Designed a disease potential-driven attention mechanism for risk assessment and mask construction.
Main Results:
- The DP-GA model demonstrated significant improvements in comorbidity risk prediction for hypertension patients.
- Outperformed baseline and state-of-the-art methods across three comorbidity datasets.
- Analysis of the comorbidity network enhanced prediction interpretability and early detection capabilities.
Conclusions:
- The DP-GA model offers a robust and interpretable approach for hypertension comorbidity risk prediction.
- This method effectively captures fused patient features and identifies critical relationships.
- The findings support improved clinical decision-making and patient management for hypertension.
Abstract:
Hypertension is associated with an increased risk of serious complications, and the hazards are very serious. However, current methods for predicting comorbidity risks face the challenge that comorbidity prediction relying solely on data driven may lead to clinically implausible associations and reduce model interpretability. Also, how to capture the fusion features of patient and identify differences among them to facilitate risk prediction needs to be addressed. To overcome these challenges, we propose a Disease Potential-Driven Graph Attention (DP-GA) model for comorbidity risk prediction of hypertension, which has 3-fold ideas: (a) Constructing a fusion mechanism for the correlation among the patients' disease features and the structural, thus integrating feature attention and structural attention effectively; (b) Introducing a similarity-difference balance mechanism to further identify the relationships among patients; and (c) Designing a disease potential-driven attention mechanism to calculate the disease potential and construct masks, thus preserving the effective associations from high-risk patients to low-risk patients. Experimental results demonstrate that our proposed DP-GA model achieves a significant improvement in comorbidity risk prediction for patients with hypertension across three comorbidity datasets collected by the research group, compared with both the baseline and state-of-the-art peer methods. We also analyze the comorbidity network to predict the risk of hypertension comorbidity, thereby improving interpretability and early prediction of such comorbidities.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension I: Introduction
Hypertension and Regulation of Blood Pressure
Hypertension III: Clinical Manifestations and Diagnostic Studies
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
Pre-Procedural Guidelines for Assessing Blood Pressure

